Mishra, Vivek Kumar <br/><br/>
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.  [electronic resource] 

 -  Nucleic acids research  Jun 2017 
 - 6334-6349 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1362-4962 
<br/><br/><label>Standard No.: </label>10.1093/nar/gkx212  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Benzamides--pharmacology<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Cell Cycle Proteins<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Epithelial-Mesenchymal Transition<br/>Gene Expression<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Histone Deacetylase 1--metabolism<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Mice, Nude<br/>Nuclear Proteins--physiology<br/>Pancreatic Neoplasms--drug therapy<br/>Phenotype<br/>Proto-Oncogene Proteins c-myc--physiology<br/>Transcription Factors--physiology<br/>Xenograft Model Antitumor Assays